George and Charlie, born in 1998, were the first cloned transgenic calves, paving the way for "pharming".

With "pharming", scientists hope to combine cloning and genetic modification to create animals capable of producing medicinal products.

One of the calves' creators is now president of a company aiming to produce human antibodies.